BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16357395)

  • 1. Comparison of gadobenate dimeglumine-enhanced dynamic MRI and 16-MDCT for the detection of hepatocellular carcinoma.
    Kim YK; Kim CS; Chung GH; Han YM; Lee SY; Chon SB; Lee JM
    AJR Am J Roentgenol; 2006 Jan; 186(1):149-57. PubMed ID: 16357395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of superparamagnetic iron oxide-enhanced and gadobenate dimeglumine-enhanced dynamic MRI for detection of small hepatocellular carcinomas.
    Kim YK; Kim CS; Lee YH; Kwak HS; Lee JM
    AJR Am J Roentgenol; 2004 May; 182(5):1217-23. PubMed ID: 15100122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma in liver transplantation candidates: detection with gadobenate dimeglumine-enhanced MRI.
    Choi SH; Lee JM; Yu NC; Suh KS; Jang JJ; Kim SH; Choi BI
    AJR Am J Roentgenol; 2008 Aug; 191(2):529-36. PubMed ID: 18647927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI versus gadobenate dimeglumine (Gd-BOPTA)-enhanced MRI for preoperatively detecting hepatocellular carcinoma: an initial experience.
    Park Y; Kim SH; Kim SH; Jeon YH; Lee J; Kim MJ; Choi D; Lee WJ; Kim H; Koo JH; Lim HK
    Korean J Radiol; 2010; 11(4):433-40. PubMed ID: 20592927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of combining sequentially acquired gadobenate dimeglumine-enhanced magnetic resonance imaging and resovist-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: comparison with computed tomography hepatic arteriography and computed tomography arterioportography using 16-slice multidetector computed tomography.
    Kim YK; Kwak HS; Han YM; Kim CS
    J Comput Assist Tomogr; 2007; 31(5):702-11. PubMed ID: 17895780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumine-enhanced MR imaging and multiphasic 64-section CT.
    Marin D; Di Martino M; Guerrisi A; De Filippis G; Rossi M; Ginanni Corradini S; Masciangelo R; Catalano C; Passariello R
    Radiology; 2009 Apr; 251(1):85-95. PubMed ID: 19332848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of hepatocellular carcinoma by Gd-EOB-DTPA-enhanced liver MRI: comparison with triple phase 64 detector row helical CT.
    Akai H; Kiryu S; Matsuda I; Satou J; Takao H; Tajima T; Watanabe Y; Imamura H; Kokudo N; Akahane M; Ohtomo K
    Eur J Radiol; 2011 Nov; 80(2):310-5. PubMed ID: 20732773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.
    Kim SH; Kim SH; Lee J; Kim MJ; Jeon YH; Park Y; Choi D; Lee WJ; Lim HK
    AJR Am J Roentgenol; 2009 Jun; 192(6):1675-81. PubMed ID: 19457834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of hepatocellular carcinoma: gadoxetic acid-enhanced 3-dimensional magnetic resonance imaging versus multi-detector row computed tomography.
    Kim YK; Kim CS; Han YM; Kwak HS; Jin GY; Hwang SB; Chung GH; Lee SY; Yu HC
    J Comput Assist Tomogr; 2009; 33(6):844-50. PubMed ID: 19940648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI for detection of hepatocellular carcinoma: comparison of mangafodipir trisodium and gadopentetate dimeglumine contrast agents.
    Youk JH; Lee JM; Kim CS
    AJR Am J Roentgenol; 2004 Oct; 183(4):1049-54. PubMed ID: 15385303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
    J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small (≤ 2 cm) hepatocellular carcinoma in patients with chronic liver disease: comparison of gadoxetic acid-enhanced 3.0 T MRI and multiphasic 64-multirow detector CT.
    Hwang J; Kim SH; Lee MW; Lee JY
    Br J Radiol; 2012 Jul; 85(1015):e314-22. PubMed ID: 22167508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferucarbotran-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.
    Kim SH; Choi D; Kim SH; Lim JH; Lee WJ; Kim MJ; Lim HK; Lee SJ
    AJR Am J Roentgenol; 2005 Apr; 184(4):1069-76. PubMed ID: 15788575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of gadoxetic acid-enhanced magnetic resonance imaging and contrast-enhanced computed tomography with histopathological examinations for the identification of hepatocellular carcinoma: a multicenter phase III study.
    Tsurusaki M; Sofue K; Isoda H; Okada M; Kitajima K; Murakami T
    J Gastroenterol; 2016 Jan; 51(1):71-9. PubMed ID: 26130441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of hypervascular hepatocellular carcinoma by dynamic magnetic resonance imaging with double-echo chemical shift in-phase and opposed-phase gradient echo technique: comparison with dynamic helical computed tomography imaging with double arterial phase.
    Noguchi Y; Murakami T; Kim T; Hori M; Osuga K; Kawata S; Okada A; Sugiura T; Tomoda K; Narumi Y; Nakamura H
    J Comput Assist Tomogr; 2002; 26(6):981-7. PubMed ID: 12488747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additional value of gadoxetic acid-DTPA-enhanced hepatobiliary phase MR imaging in the diagnosis of early-stage hepatocellular carcinoma: comparison with dynamic triple-phase multidetector CT imaging.
    Haradome H; Grazioli L; Tinti R; Morone M; Motosugi U; Sano K; Ichikawa T; Kwee TC; Colagrande S
    J Magn Reson Imaging; 2011 Jul; 34(1):69-78. PubMed ID: 21598343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of small hepatocellular carcinoma: can gadoxetic acid-enhanced magnetic resonance imaging replace combining gadopentetate dimeglumine-enhanced and superparamagnetic iron oxide-enhanced magnetic resonance imaging?
    Kim YK; Kim CS; Han YM; Park G
    Invest Radiol; 2010 Nov; 45(11):740-6. PubMed ID: 20644488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of recurrent hepatocellular carcinoma on post-operative surveillance: comparison of MDCT and gadoxetic acid-enhanced MRI.
    Kim KA; Kim MJ; Choi JY; Park MS; Lim JS; Chung YE; Kim KW
    Abdom Imaging; 2014 Apr; 39(2):291-9. PubMed ID: 24384804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative prediction of pathologic grade of HCC on gadobenate dimeglumine-enhanced dynamic MRI.
    Rong D; Liu W; Kuang S; Xie S; Chen Z; Chen F; Xie Q; Luo Q; He B; Zhang Y; Deng Y; Yang H; Chen S; Wang J
    Eur Radiol; 2021 Oct; 31(10):7584-7593. PubMed ID: 33860826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Small hepatocellular carcinoma in patients with hepatitis B-induced cirrhosis: a comparison between MRI and MDCT].
    Jiang YY; Wang XY; Guo XM; Jiang XX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Dec; 42(6):767-72. PubMed ID: 21170112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.